12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of various health care stocks on Friday. Notable gainers include Novo Integrated Sciences (NVOS), Adaptimmune Therapeutics (ADAP), and Bionomics (BNOX). Significant losers include Summit Therapeutics (SMMT), Genfit (GNFT), and Veeva Systems (VEEV).
May 31, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adaptimmune Therapeutics (ADAP) shares rose by 40.59% to $1.42 in pre-market trading, reflecting positive market sentiment.
The substantial increase in share price indicates positive market sentiment, likely resulting in a short-term price boost.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Bionomics (BNOX) shares increased by 29.56% to $1.28 in pre-market trading, showing strong investor interest.
The notable rise in share price suggests strong investor interest, likely leading to a positive short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences (NVOS) stock surged by 69.6% to $0.77 in pre-market trading, indicating strong investor interest.
The significant price increase suggests strong investor interest, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Genfit (GNFT) stock declined by 11.15% to $5.26 in pre-market trading, reflecting negative investor sentiment.
The notable decline in stock price suggests negative investor sentiment, likely leading to a short-term price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Summit Therapeutics (SMMT) stock fell by 17.9% to $8.97 in pre-market trading, indicating negative market sentiment.
The significant drop in stock price indicates negative market sentiment, likely resulting in a short-term price decline.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Veeva Systems (VEEV) shares fell by 9.11% to $176.5 in pre-market trading following the release of Q1 earnings.
The decline in share price following the Q1 earnings release suggests a negative market reaction, likely resulting in a short-term price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100